Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View

by Elizabeth A. Mills, Yang Mao-Draayer, Yang Mao-Draayer
Published 2018-02-01

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis

by Elizabeth A. Mills, Magdalena A. Ogrodnik, Andrew Plave, Yang Mao-Draayer, Yang Mao-Draayer
Published 2018-01-01

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment

by Mai Himedan MD, Sandra Camelo-Piragua MD, Elizabeth A. Mills PhD, Avneesh Gupta MD, Rany Aburashed DO, Yang Mao-Draayer MD, PhD
Published 2017-09-01